Capital, a curriculum, and a network — from a fund that invests in AI healthcare and nothing else. We write you a check on day one, run a focused 10-week program built around your company, and put you in front of a room full of investors at Demo Day in New York. Scientists first. Investors second.
"Every person teaching you is an active check writer. Any one of them could be your next investor."
Before week one, we read your prior application to the fund, the exact feedback from the IV Team and our Executive LP Committee, and our own diligence — to pinpoint why you haven't been funded yet. The ten weeks are built around turning those gaps into strengths, with guest lecturers pulled in wherever the cohort needs them.
"No spray-and-pray syllabus. If you've already mastered something, we won't make you sit through the 101."
Applications are open for the September 2026 cohort. We read every one.
We don't fund therapeutics. We cap what we take. And we don't pretend ten weeks replaces ten years of operating. What we do is concentrate the right people, capital, and counsel around your company at the moment it matters most — then keep showing up after Demo Day.